Mental Health DailyResearch. Evidence. Perspective.Published research on Drugs.
For individuals in the United States between the age of 15 and 44, major depression is the leading cause of disability. Major depression is often a heritable condition, caused by maladaptive…
Read articleIt is estimated that over 2.5 million adults in the United States have been diagnosed with schizophrenia; this equates to approximately 1.1% of the population. There are many different types…
Read articleFluoride is considered a colorless inorganic anion of the chemical fluorine and is commonly used as an additive in drinking water to improve dental health. Adding fluoride to tap water is a …
Read articleInvega (Paliperidone) is considered a newer spin-off of the antipsychotic Risperdal in that it contains the same active metabolite, but is thought to have fewer side effects and drug interac…
Read articleInvega (Paliperidone) is an atypical antipsychotic approved in 2006 for the treatment of schizophrenia. Several years later in 2009, a longer-acting format of the medication called “Invega S…
Read articleFanapt (Iloperidone) is an antipsychotic that was approved in 2009 for the treatment of schizophrenia. It functions similar to most current-market atypical antipsychotics in that it acts as …
Read articleFanapt (Iloperidone) is an atypical antipsychotic that was approved by the FDA on May 6, 2009 for the treatment of schizophrenia. The drug is thought to have been synthesized in the 1990s, d…
Read article